Illinois Cannabis & Hemp Client Alert Illinois Enacts Sweeping Cannabis and Hemp Reform: What Operators Need to Know Now

On June 12, 2026, Illinois Governor J.B. Pritzker signed Senate Bill 3222 into law, marking the most significant overhaul of the state’s cannabis and hemp regulatory framework since the Cannabis Regulation and Tax Act was enacted in 2019. The new law creates the Illinois Hemp Act, substantially restructures the medical and adult-use cannabis markets, expands cultivation and retail opportunities, and establishes a social equity pathway for qualifying hemp businesses to transition into the licensed cannabis industry—all on a compressed timeline aligned with a November 2026 federal hemp ban.

Whether you operate in the licensed cannabis market, the hemp-derived products sector, or both, SB 3222 will have significant implications for your business. A detailed two-page breakdown with pinpoint citations and compliance timelines accompanies this alert—below, we focus on what matters most and what you should be doing now.

For Cannabis Operators

The bill pairs long-sought operational wins—doubled possession limits, drive-through dispensing, 2 a.m. closing, craft grower canopy tripled to 14,000 sq ft, and in-house security—with new compliance obligations that require immediate planning. Most notably:

• Medical license integration: Adult-use dispensaries can add a Medical Cannabis Dispensing Organization License 90 days after the effective date, opening access to medical patients at lower tax rates—but with inventory and prioritization obligations.
• MSA caps: Hard payment thresholds (10% of monthly gross revenue, 50% of net profits, or $250K/year) now may trigger principal officer classification. Existing management and consulting arrangements may need restructuring.
• New infuser licenses: At least 45 by January 2027, up to 145 total by 2028, reserved for social equity applicants including qualifying hemp businesses.

For Hemp Operators

The Illinois Hemp Act takes effect November 12, 2026.

• Any product exceeding 0.4 mg total THC per container cannot be sold outside a licensed dispensary.
• Delta-8, Delta-10, HHC, THC-O, and all synthetically derived cannabinoids are banned.
• Smokable and vapeable hemp products are prohibited.

This effectively will eliminate a majority of products currently sold throughout the state. Additionally, the bill does not refer back to the federal law, meaning any “fix” at the federal level will not automatically flow through to Illinois businesses.

The bill offers a transition on-ramp: hemp businesses operating by May 1, 2026 may qualify for the infuser license lottery. But the license supply will not accommodate every current operator. Planning should begin now.

What You Should Be Doing Now

Cannabis operators: Evaluate the medical license opportunity and associated operational changes. Reassess security staffing and canopy expansion plans. Review MSA/consulting arrangements for compliance and/or waiver requests.

Hemp operators: Audit your product line against the 0.4 mg THC cap and prohibited cannabinoid list. Determine infuser license eligibility. Prepare for testing, labeling, and packaging compliance ahead of November 12. Decide whether your business model is viable under the new framework—or whether the licensed cannabis market is the better path forward.

See the accompanying two-page cheat sheet for a full provision-by-provision breakdown with statutory citations and compliance timelines.

How We Can Help

At Dentons, our Cannabis Sector Group has been at the center of Illinois cannabis and hemp policy for over a decade. We are helping operators, investors, and ancillary businesses assess compliance exposure, restructure agreements, and develop practical roadmaps for the changes ahead.

Eric Berlin | Partner, Chicago | Lead, Dentons Cannabis Sector Group D +1 312 876 2515 | eric.berlin@dentons.com

Joanne Caceres | Partner, Chicago D +1 312 876 2862 | joanne.caceres@dentons.com

This alert is for informational purposes only and does not constitute legal advice.